Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1140 related articles for article (PubMed ID: 20471303)

  • 1. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
    Lai SY; Johnson FM
    Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer.
    Mali SB
    Oral Oncol; 2015 Jun; 51(6):565-9. PubMed ID: 25817923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the interleukin-6/Jak/stat pathway in human malignancies.
    Sansone P; Bromberg J
    J Clin Oncol; 2012 Mar; 30(9):1005-14. PubMed ID: 22355058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
    Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
    Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
    Waldmann TA; Chen J
    Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JAK-STAT pathway: a therapeutic target in hematological malignancies.
    Ferrajoli A; Faderl S; Ravandi F; Estrov Z
    Curr Cancer Drug Targets; 2006 Dec; 6(8):671-9. PubMed ID: 17168672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT Signaling in Glioma Cells.
    Swiatek-Machado K; Kaminska B
    Adv Exp Med Biol; 2020; 1202():203-222. PubMed ID: 32034715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
    Reddy EP; Korapati A; Chaturvedi P; Rane S
    Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
    Heim MH
    J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.
    Chaturvedi P; Reddy MV; Reddy EP
    Oncogene; 1998 Apr; 16(13):1749-58. PubMed ID: 9582023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.
    Wang G; Qian P; Jackson FR; Qian G; Wu G
    Int J Biochem Cell Biol; 2008; 40(3):461-70. PubMed ID: 17920330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
    Groner B; von Manstein V
    Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
    Alunno A; Padjen I; Fanouriakis A; Boumpas DT
    Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.